Representative Settlements

Berger & Montague acted as one of the Court appointed lead counsel on behalf of a certified class of purchasers of art materials, products used extensively by children and regulated by the government, including crayons oil paints and finger paints,...

Berger & Montague, P.C. was a member of the court-appointed Executive Committee of attorneys representing a class of direct purchasers of automotive refinishing paint in In re Automotive Refinishing Paint Antitrust Litigation, MDL Docket No. 1426...

With Berger & Montague as sole lead counsel, this landmark action on behalf of a national class of more than 100,000 gasoline dealers against 13 major oil companies led to settlements of over $35 million plus equitable relief on the eve of trial

The firm served as co-lead counsel in this antitrust price-fixing class action on behalf of a class of purchasers of brand name prescription drugs. Following certification of the class by the district court, settlements exceeded $717 million

Berger & Montague was a member of the court-appointed Steering Committee of firms representing the class in the In re Buspirone Antitrust Litigation, MDL Docket No. 1410. The case was litigated before the United States District Court for the...

Berger & Montague was one of four Co-Lead Counsel in an action alleging price-fixing conduct among the producers of Carbon Black, a product used principally in tires, plastics and ink. The action was filed in 2002 and was settled after a summary...

Berger & Montague was Co-Trial Counsel in this antitrust class action which settled with the last defendant days prior to trial for total settlements approximating $53 million, plus injunctive relief. (MDL No. 940 (M.D. Fla.)).

On November 26, 2002, the U.S. District Court for the Eastern District of Michigan approved a final settlement of this case in which both defendants, Aventis Pharmaceuticals and Andrx Pharmaceuticals, agreed to pay the previously certified class of...

The firm was co-trial counsel in this action which settled with the last defendant a week before trial, for total settlements approximating $27 million.

Berger & Montague played a significant role participating as Co-Lead and Co-Trial Counsel in this landmark class action on behalf of nationwide classes of purchasers of corrugated boxes and sheets from 37 manufacturer/defendants. The litigation...

This action was brought on behalf of a class of United States holders of Visa, MasterCard, and Diners Club credit or charge cards who incurred fees on credit card transactions in a foreign currency or with a foreign merchant. The class action alleges that the defendants conspired to artificially set and inflate currency conversion fees United States cardholders incur each time they use their cards in foreign currency transactions or with a foreign merchant. The action also alleges that defendants violated their disclosure obligations under Truth In Lending Act to disguise these fixed conversion fees from cardholders.

Berger & Montague was Co-Lead Counsel for a class of direct purchasers of the tablet form of DDAVP, an anti-diuretic drug used to treat excessive urination. The defendants, Ferring B.V., Ferring Pharmaceuticals, Inc. and Aventis Pharmaceuticals,...

A proposed class of direct purchasers of endosurgical products - miniaturized surgical devices used to conduct surgery through small incisions on a patient's body - has alleged that Johnson & Johnson, Inc. forced purchasers of its sutures to pay price penalties on their purchases if they bought endosurgical products from any of J&J's rivals.

Berger & Montague was Lead Trial Counsel in this antitrust class action prosecuted on behalf of a class of fashion models, after several major New York modeling agencies fixed their commissions. The case settled for a total of $21.8 million, with...

Berger & Montague played a prominent role in the litigation serving as one of the court-appointed Co-Lead Counsel. Two antitrust class actions were before the late Honorable Charles R. Weiner of the Eastern District of Pennsylvania on behalf of...

Berger & Montague, as one of three Co-Lead Counsel, recovered settlements totaling $531 million on behalf of a class of direct purchasers of high fructose corn syrup (HFCS). HFCS is the principal sweetener used in non-diet sodas as well as in many...

Berger & Montague served as Co-Lead Counsel in an antitrust case alleging that three manufacturers of infant formula (Abbot Labs, Bristol-Meyers Squib and American Home Products) conspired to raise prices. The District Judge, Maurice M. Paul,...

Berger & Montague is Co-Lead Counsel for a class of temporary nursing personnel who allege they were underpaid as a result of an unlawful agreement among Arizona hospitals to fix and suppress what the hospitals paid for such temporary work. On...

Berger & Montague was one of a small group of court-appointed Executive Committee members who led this nationwide class action against producers of linerboard. The complaint alleged that the defendants conspired to reduce production of linerboard in...

Berger & Montague filed this antitrust suit on behalf of the City of Philadelphia and served as one of the Co-Lead Counsel in this litigation. Plaintiffs alleged that four manufacturers of master key systems violated Section 1 of the Sherman Act by...

Berger & Montague, as one of four court-appointed Co-Lead Counsel, recovered more than $15 million in settlements for the benefit of direct purchasers of methyl methacrylate ("MMA") and acrylic products. MMA is the key ingredient used in the...

Berger & Montague was one of two Co-Lead counsel in the case on behalf of a class of wholesalers and pharmacies, alleging that AztraZeneca used a fraudulently obtained patent to block the entry of lower priced generic competitors to their brand-name prescription medication, sold under the brand name Toprol XL. The suit alleged that the anticompetitive conduct forced all purchasers to overpay for this prescription medication.

Berger & Montague, as one of two court appointed Co-Lead Counsel, recovered $50 million in settlements for the benefit of direct purchasers of microcrystalline cellulose ("MCC"). MCC is a chemical derived from purified wood cellulose. Its...

Berger & Montague was among the Lead Class Counsel in this antitrust class action on behalf of direct purchasers of the oral birth control medication, Ovcon 35. The class accused the defendants Warner Chilcott and Barr Pharmaceuticals of entering...

Plaintiffs, represented by Berger & Montague, alleged that Defendant Purdue Pharmaceuticals filed bogus patent prosecution actions in an effort to crush competition from generic competitors.